Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Crystallin gamma F, pseudogene (CRYGFP) is part of the human gamma-crystallin gene cluster located on chromosome 2q34[2]. While in some mammals it encodes a structural lens protein, in humans it is designated a pseudogene: the gene sequence remains largely intact but there is no evidence of functional expression—neither mRNA nor protein has been detected[2]. Pseudogenes like CRYGFP may have potential, though rare, roles in gene conversion events but are not expressed under normal physiological conditions. The gamma-crystallin family forms highly stable lens proteins important for transparency and refractive index, but CRYGFP itself does not contribute to these functions in humans[1][2]. It is not implicated in disease, not known to interact with drugs, and is not used as a biomarker. It does not belong to molecular classes typically considered druggable targets (e.g., receptor, enzyme, transporter)[2].\n\nThe designation as a pseudogene means it is a relic of gene duplication and evolutionary processes. Species like mice have a functional gamma-crystallin F; in humans, loss of function is typical for this locus[2]. Only CRYGC and CRYGD within this gene cluster are major contributors to lens structure and some forms of hereditary cataract, but CRYGFP has no such role[2]. \n\nIf you are seeking a therapeutic target or protein relevant to disease, CRYGFP does not meet those criteria. The information provided above follows conventions to clarify its status and classification.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Crystallin gamma F, pseudogene (CRYGFP).